Do blood thinners + stroke treatment = danger? Study indicates the risk is low
Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots.
Cardiology
Mar 13, 2013 |
not rated yet |
0
|
Rivaroxaban has less risk of brain bleeding in patients at high risk for stroke
For patients with a type of irregular heart beat called atrial fibrillation (AF), a new anti-clotting drug might be better at preventing clot-related strokes while minimizing the risk of causing a bleeding stroke. The research ...
Cardiology
Feb 02, 2012 |
not rated yet |
0
New blood thinner may lower chances of clots in high-risk heart patients: FDA
(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.
Medications
May 21, 2012 |
not rated yet |
0
More GI bleeding seen in atrial fibrillation patients on rivaroxaban than warfarin
Patients with atrial fibrillation (AF) experienced more major and non-major clinically relevant GI bleeding when taking rivaroxaban than patients taking warfarin.
Cardiology
Oct 22, 2012 |
not rated yet |
0
Stroke risk high when anti-clotting drugs stopped
Some patients with irregular heartbeats who are taken off anti-clotting medication face a high risk of stroke or blood clotting within a month, according to new research presented at the American Heart Association's Emerging ...
Cardiology
Apr 25, 2012 |
not rated yet |
0
Xarelto's approval expanded
(HealthDay)—Approval of the anti-clotting drug Xarelto (rivaroxaban) has been expanded by the U.S. Food and Drug Administration to include treating deep vein thrombosis (DVT) or pulmonary embolism.
Medications
Nov 05, 2012 |
not rated yet |
0
Rivaroxaban found noninferior to enoxaparin in acutely ill
(HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
Study shows ability of new agent to prevent strokes in patients with atrial fibrillation
In the primary result from the largest double-blind study ever completed to assess a drug's effect in the prevention of stroke in patients with atrial fibrillation, a common heart rhythm abnormality, rivaroxaban, an anti-clotting ...
Cardiology
Aug 10, 2011 |
3 / 5 (1) |
0
Anti-clotting drug lowers risks in acute coronary syndrome treatment
An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American ...
Cardiology
Nov 14, 2011 |
not rated yet |
0
|
